Abstract
Background
Total joint arthroplasty (TJA) is considered one of the most successful surgical procedures ever developed. It can successfully provide pain relief, restore joint function, and improve mobility and quality of life. Prosthetic joint infection (PJI) presents with a wide variety and severity of signs and symptoms. It remains a major threat to the outcome of TJA procedures and usually necessitates surgical intervention and prolonged courses of antibiotics. Inappropriate treatment of an unrecognized PJI usually ends with unacceptable and sometimes catastrophic results.
The aim
The understanding and evaluation of diagnostic investigations are extremely important to properly diagnose PJI, including frequently unrecognized low-grade infections, and to provide healthcare professionals with needed information for the care of patients affected by this condition. This article aims to review most of the methods available in PJI diagnostics, to emphasize the strengths and the weaknesses of each of them, and to provide a guideline on how to select the surgical treatment strategy based on the level of diagnostic certainty during the evaluation period. To safely accomplish this, it is crucial to be aware of the limitations of each diagnostic modality.
The focus
The emphasis will be on the use and interpretation of the core criteria for PJI diagnosis, including the pathognomonic sinus tract communicating with the implant, purulent synovial fluid, inflammation in the periprosthetic tissue, cell count with differential, microbial growth in the synovial fluid culture, tissue sample cultures, and sonication samples.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
TJA (total joint arthroplasty) failures include a wide variety of clinical presentations [1, 2]. PJI (prosthetic joint infection) represents the second most frequent, but also the most important complication of TJA after aseptic loosening. The number of PJI is increasing because of the larger number of arthroplasty surgery worldwide and the growing awareness of “low grade” PJI [3]. PJI may present as an acute fulminant disease with sepsis but it could be also completely asymptomatic [4]. Most of the PJIs present with signs and symptoms between these two extremes. High-grade PJI can be a life- or limb-threatening condition necessitating immediate action. However, it is usually easy to diagnose. Whereas low-grade PJI is mostly presenting with early loosening, or pain only, it can be very difficult to diagnose. During recent years, we have become increasingly aware that, in addition to obvious PJI, there is an important but unknown number of septic failures—PJI hiding within “aseptic failure” cohorts [5,6,7]. Recent papers are presenting significant numbers of up to 20% of low-grade PJI within presumed aseptic failure cohorts [7, 8]. Many early failures after revision TJA fit within this overlooked PJI group [7,8,9,10]. The main challenge of the diagnostic evaluation is to accurately differentiate between septic and aseptic TJA failure because the treatment is different (Table 1).
There is still no single test to reliably diagnose all PJIs. Therefore, a variety of different combinations of diagnostic tests were proposed to improve the accuracy of the PJI diagnostics. There are currently five popular diagnostic criteria available for PJI: Musculoskeletal Infection Society (MSIS), Infectious Disease Society of America (IDSA), International Consensus Meeting (ICM), ProImplant, and European Bone and Joint Infection (EBJIS). The main differences among them are the selection and rank of the included diagnostic investigations resulting in sensitivity and specificity differences. The use of specific but not sensitive criteria raises the possibility of missing a significant proportion of PJI, while the use of sensitive but not specific criteria means that some of the patients with aseptic failure would be diagnosed as septic. The consequence of the suboptimal accuracy of the diagnostic criteria available is that misdiagnosed patients are not treated appropriately. Patients with misdiagnosed PJI receive inadequate treatment in terms of surgical and antimicrobial aspects [7, 9]. If low-grade PJI is not recognized and treated properly, infection generally persists, and it can lead to early loosening and multiple revisions with functional loss and disability severely impairing the quality of life [9, 11,12,13]. In contrast, by increasing PJI diagnostic sensitivity, aseptic conditions may be diagnosed as septic with the consequent over treatment. The incidence and morbidity of under diagnosed PJI are significant and relatively well documented, while the incidence and negative consequences of overtreatment of aseptic failures as PJI have not yet been thoroughly analyzed. By selecting sensitive criteria for less invasive treatment options and specific criteria for more aggressiveness, we can minimize the damage incurred due to the suboptimal PJI diagnostic accuracy of the available diagnostic criteria and diagnostic tests.
The treatment of PJI is complex including surgery and prolonged antibiotic therapy [14, 15]. After surgery, antibiotics are given intravenously for one to three weeks continuing orally for additional ten weeks. If the implant is retained or directly exchanged antibiofilm antibiotics, rifampicin for staphylococci and quinolones for Gram-negative agents improve significantly the chances for a cure. Surgical treatment of PJI includes three main options:
-
1.
Debridement and implant retention (DAIR), indicated in early acute PJI if radicaldebridement is feasible when the biofilm is still immature, mostly up to four weeks after implantation, or in late acute presentation after haematogenous spread
-
2.
One-stage exchange (OSE) is mostly indicated in chronic PJI if radical debridement is feasible
-
3.
Two-stage exchange (TSE), indicated for most remaining PJI presentations
Other treatment possibilities, antibiotic suppression, iatrogenic sinus tract formation, and amputation are reserved for special circumstances. The selection of the best surgical option depends on the presumed duration of infection, debridability, microbiology, and to a lesser extent the degree of bone and soft tissue loss, implant type, and general patient conditions. An artificial joint is considered debridable, when it is possible to remove a sizable layer of the infected, necrotic, and granulomatous or fibrotic tissues all around the artificial joint cavity without removing functional tissues such as nerves, major vessels, and tendons [14].
The main guideline for the selection of the best care for PJI patients is to select the least invasive treatment option for the best functional result and without compromising the microbiological cure.
In comparison to the reviews available to date, the presenting review emphasizes the strengths, the weaknesses, and the evidence of each of the diagnostic modality and places the whole diagnostic process into clinical context, providing guidelines for surgical treatment.
Patient evaluation
The evaluation of the patient with a presumed PJI aims to obtain all the necessary information for optimal treatment planning. The process includes PJI diagnostic procedures for accurate detection of all types of PJI and/or exclusion of many differential diagnoses that can clinically mimic PJI but also the assessment of the general medical condition and the status of the affected joint. The diagnostic process starts before surgery and ends after all intra-operative examinations are completed. Until then, the patient should be treated as having a PJI. Close cooperation among various specialists including orthopaedic surgeons, infectious disease experts, microbiologists, and pathologists is needed [16].
General clinical evaluation is required for assessing the severity of the PJI, the comorbidities that may influence the treatment plan, and to identify the eventual visceral or musculoskeletal origin of TJA pain that can mimic PJI. Pain in the artificial joint may result from other conditions, and therefore assessment of the spine and other ipsilateral joints is also necessary [11, 13, 17, 18].
Patients with clinical signs of acute PJI showing systemic symptoms such as fever and local pain, erythema, oedema, and impaired prosthetic joint function should have a pre-operative diagnostic aspiration and be prepared for surgery as soon as possible. The pre-operative evaluation is crucial because even in patients with clear clinical presentations of the acute PJI clinical picture can be also due to aseptic reasons, or the septic process is not involving the joint [11, 13].
Less acute patients presenting with clinical symptoms of PJI should undergo an evaluation with a thorough workout to determine the probability of PJI. This helps in the decision about the treatment plan. Pre-operative investigations for PJI are limited to the aspiration for cytology and microbiology and bone scans. Since these are frequently inconclusive, the probability of PJI based on patient history is crucial for the decision between the septic or aseptic treatment pathway. Clinical symptoms and signs indicating a high degree of probability for PJI are presented in Table 2 [11].
The laboratory evaluation should be tailored to support the general assessment of the patient before the eventual surgical procedure. C-reactive protein (CRP) is generally elevated in PJI but is often normal in low-grade PJI. Along with the history and clinical evaluation, it can be helpful in the selection of patients suitable for the PJI diagnostic process.
A recent plain radiograph of the affected joint should be obtained, and, if clinically indicated, of other joints and the spine. Other imaging modalities may be needed for surgery planning and for ruling out aseptic conditions potentially affecting the failed prosthetic joint.
It is essential to perform a systematic general and joint-specific evaluation to determine the probability of PJI in all unclear situations with the joint pending revision.
Diagnostic investigations for PJI evaluation
Different diagnostic criteria reflect the wide range of tests available for PJI diagnostics. In general, it is important to consider at least clinical, histological, cytological, and microbiological parameters when selecting PJI diagnostics.
Clinical diagnosis
There are two clinical pathognomonic features of PJI: sinus tract communication with the implant and purulence around the implant. There is a universal agreement that a sinus tract communicating with the joint confirms PJI. When there is doubt if the sinus is extending into the joint cavity, the injection of methylene blue into the joint is the best way to obtain the diagnosis. If the methylene blue leaks out from the sinus, the diagnosis is confirmed. Purulence needs to be interpreted with greater caution because a range of conditions can cause macroscopically purulent but aseptic synovial liquid. The most frequent reasons are adverse tissue reactions associated with metal-on-metal attrition in the TJA (due to metal-on-metal bearing or any other situation where there is dynamic contact between metallic materials and other metallic or ceramic components) and/or corrosion [19]. Aseptic purulence can also result from crystal, reactive, or inflammatory arthritis [20, 21]. After excluding these possibilities, purulence is no longer a controversial criterion and has close to 100% specificity.
Histological diagnosis
Histology is a standard, well-studied diagnostic modality with evidence indicating sensitivity and specificity above 90%. The diagnosis depends on the concentration of neutrophils in the periprosthetic membrane or capsular tissue (the former providing more accurate analysis). A comprehensive review of the available evidence regarding how to harvest, perform, and utilize the histological techniques has been published recently [22]. The presence of PJI is usually determined by the count of neutrophils per high-power field at 400-times magnification [23]. Different researchers have offered ranges from ≥ one to ≥ ten neutrophils per high-power field [24]. Neutrophils can also be detected with immunohistochemical techniques and validated by histopathological scores [25]. By using the CD15 focus score, the optimum threshold for diagnosing PJI was defined as 39 CD15+ neutrophil granulocytes/focal point. Histopathology differentiates to some extent between high or low virulence PJI [26, 27].
Recently a standardization of histopathological findings with a new classification based on clear morphological criteria that cover the complete spectrum of histopathology in the periprosthetic membrane has been proposed. The classification has the following seven distinct pathological types: I, particle-induced; II, infection; III, combination; IV, indifferent; V, arthrofibrotic; VI, allergic/immunological/toxic adverse reactions; and VII, bone pathologies [26].
Cytological diagnosis
Joint aspiration is the single most important pre-operative diagnostic tool used for evaluating patients for suspected PJI. It should be performed in every painful prosthetic joint before surgical revision. To avoid dry tap, it is advisable to use advanced imaging including CT or ultrasound for needle guidance to the synovial fluid pouch [28,29,30]. Joint aspiration is the only pre-operative test that can discover the causative microbiological agent. It is perhaps even more important for leukocyte count and differential determination and represents the simplest, most rapid, and accurate test for differentiating between PJI and aseptic failure. Several cutoffs have been proposed by different authors [24, 25, 31,32,33,34,35]. If DAIR and OSE are planned, sensitive PJI diagnostic cutoffs should be considered. Recent studies using sensitive methods such as sonication suggest 2000 leukocytes/μL and 70% granulocytes as the optimal composite cutoff value [24, 31, 32]. Since the cell count (as well as histology) depends on the inflammatory induction capacity (virulence) of the causative organism, it is expected that a lower threshold would be needed for shoulder PJI because of the higher proportion of low virulence organisms (e.g., Cutibacterium species). For optimal interpretation of the cell count, it is necessary to take into consideration the special circumstances outlined in Table 3.
Microbiological diagnosis
Microbiological diagnosis is based on the culture of the synovial fluid taken either before or during surgery, cultivation of intra-operative tissue samples, or cultures of the sonication fluid. There is limited evidence on exploratory tissue sampling in PJI diagnostics. It could be considered a last resort if a comprehensive pre-operative evaluation of a painful TJA does not result in a diagnosis. Swabs have no place in PJI diagnostics [37].
Synovial fluid culture
Synovial fluid culture is not very sensitive. A recent meta-analysis showed a pooled sensitivity of 72% and a specificity of 95%. Other studies showed the sensitivity between 45 and 75% with a specificity of 95% [38,39,40]. Inoculation of the synovial fluid in blood culture media improves sensitivity and decreases problems with long transport, delayed processing, and inadequate transport media. The pediatric blood culture bottle requires a low volume of synovial fluid which makes it the ideal choice when a limited amount of synovial fluid is available [41]. A long incubation time of 14 days or more is necessary to detect low virulent and difficult-to-detect pathogens such as the Cutibacterium species. One positive synovial fluid culture is insufficient to diagnose PJI. If also the second culture is positive for the same organism, the specificity is high enough to confirm the diagnosis. A combination of one positive synovial fluid culture and a positive cell count or differential is also diagnostic.
Tissue samples
Tissue sample cultivation is the most important intra-operative diagnostic procedure. From five to six intra-operative tissue samples have been calculated as the optimal number for microbiological investigations. The sensitivity of tissue cultures ranges from 65 to 94% [42]. Intra-operative swabs are not useful for PJI diagnostics due to their low sensitivity [43]. Superficial wounds or sinus tract swabs can be particularly misleading and should be avoided because the frequency of detecting colonizing rather than infecting organisms is too high.
Sonication
Sonication was introduced by Tunney in the 1990s and then popularized by Trampuž [44]. It is based on low-frequency ultrasound waves passing through the liquid surrounding the prosthesis for the detachment of biofilm microorganisms from the implant surfaces. To avoid contamination, explants should be directly placed in a sterile, airtight container in the operating theatre and not in a plastic bag [45]. The sonication fluid is inoculated on aerobic and anaerobic plates and cultured. Inoculation of the sonication fluid in blood culture bottles probably improves the sensitivity and reduces the cultivation time [46, 47]. A cutoff value of 50 colony-forming units (CFU)/ml of sonication fluid yields a sensitivity of 79% and a specificity of 99% for the diagnosis of PJI [44]. In most studies, the culture of sonication fluid shows superior sensitivity compared with the culture of multiple periprosthetic tissue samples [44, 48]. In one study, sonication had similar sensitivity as tissue biopsies, but the combination of the two had the highest sensitivity [49]. Sonication is particularly appropriate for patients who are receiving or have recently received antibiotic treatment and in chronic PJI with mature biofilm. Sonication of implants with a covering of antibiotic-loaded bone cement or bone cement itself may inhibit bacterial growth and lead to false-negative results caused by increased antibiotic elution during sonication [50]. It is thus preferable to take implant parts for sonication before removal of bone cement because high amounts of antibiotics are released from antibiotic-loaded bone cement during cement cracking.
Gram staining
Gram staining for detecting living organisms in the synovial fluid has very low sensitivity accompanied by 100% specificity. The examination is usually positive in high-grade PJI, which is generally easy to diagnose. Gram staining can be particularly effective in ambiguous cases associated with crystal or inflammatory arthritis or with an infection. If positive, it gives immediate confirmation of the diagnosis and is very helpful for the selection of empirical antibiotics by distinguishing between Gram-positive and Gram-negative organisms [41].
The significance of other traditional and novel tests for PJI diagnostics
Several other tests in the diagnostic armamentarium can be useful for evaluating patients with suspected PJI. However, each of them has certain strengths and shortcomings.
Serologic tests
Routine blood tests like white blood cell count (WBC), C-reactive protein (CRP), and procalcitonin (PCT) are useful for the general evaluation of patients but do not have sufficient sensitivity or specificity to diagnose or exclude PJI [42, 51]. Patients with low-grade PJI frequently have normal systemic inflammatory markers [52]. CRP is normal in around 30% of culture-proven PJI [51]. CRP is elevated after surgery, reflecting post-interventional inflammation, and gradually decreases afterward [53]. Itself, it has a limited role in the evaluation of PJI, but it is important for the early postoperative follow-up of patients after PJI treatment [54]. Erythrocyte sedimentation rate (ESR) is becoming obsolete because it is not sufficiently specific [55]. Novel serum markers based on coagulation-related indicators, such as D-dimer and serum fibrinogen that detect fibrinolytic activity, have been proposed for pre-operative detection of PJI. The results of initial studies are controversial with specificity and sensitivity within the same range as CRP [56].
Alpha defensin
Defensins are antimicrobials secreted by neutrophils when microorganisms target during infection [57]. Alpha defensin (AD) has been extensively studied as a biomarker for the detection of PJI [57, 58]. There are two AD tests: the fast lateral-flow qualitative test (ADFL) and the quantitative ELISA test. Gehrke et al. demonstrated similar accuracy of both tests on a high number of patients with the same criteria with no significant difference in sensitivity and specificity in the synovial fluid between the two test types [59]. ADFL is a qualitative test for detecting AD in synovial fluid and can be performed during surgery in the operating theater or within ten minutes of any joint aspiration. The first studies, mostly based on MSIS criteria, have shown AD as a promising marker [60]. In recent studies, with more sensitive definition criteria, ADLF showed much lower sensitivity (54.4−77%) while the specificity remained high at 99.3% [13, 61]. The test is not suitable for screening because of its low sensitivity but it remains a good confirmatory test because of its high specificity. Compared to a more sensitive cell count, ADFL is associated with higher costs and lower availability.
Leukocyte esterase
Leukocyte esterase has been proposed as an off-label application for intra-operative diagnostics of PJI. A high percentage—up to 33% of non-readable tests—is the main disadvantage of the method [59]. Another shortcoming is a difficult interpretation of the intermediate results. Nevertheless, it has the advantage of being a cheap and fast test suited for the intra-operative application.
Emerging diagnostic modalities
Insufficient specificity is a common problem with DNA-based molecular diagnostics but the perspective is promising and its role is growing [62,63,64]. Its main importance is in culture-negative infections, providing a clue to the potential etiologic agent. There are other emerging tests including synovial CRP, synovial cytokines, calprotectin, and adenosine deaminase that also show diagnostic promise. Most of these tests have not been extensively studied and some are not readily available [34, 65, 66]. D-lactate is a new synovial marker with high PJI diagnostic potential because it is secreted by the bacteria rather than by the host defense cells [67].
The role of nuclear imaging in diagnosing PJI is evolving. This modality is important because it helps determine the pre-operative probability of PJI. The three-phase bone scintigraphy is not useful in the first 2 years due to bone remodeling around the prosthesis. But after two years, it detects a pathologic process around the joint. Although it is not very specific for PJI, it has a high accuracy for ruling out PJI. The labeled leukocyte scan is probably the best nuclear imaging modality available for PJI diagnostics, particularly if augmented with a bone marrow scan to avoid a false-positive outcome in patients with active bone marrow around the failed TJA. The sensitivity and specificity are high in active PJI but not yet determined for low-grade PJI [68].
Conclusions
In aseptically failed TJA, the expected treatment outcomes and the probability of the complications need to be compared to the disabilities incurred by the failed joint. Frequently the potential harms of the treatment and expected outcome do not justify intervention. In PJI, the situation is different in the case of high-grade processes where treatment is saving life or limb. However, it is similar in many low-grade PJI, where the quality of life even after successful extensive treatment of the PJI may be lower than the quality of life before treatment due to treatment-incurred systemic or local damage and/or complications.
The diagnostic threshold for PJI should be considered along with the planned surgical modality. DAIR and OSE require sensitive diagnostic criteria, while invasive TSE requires specific criteria. Although it is preferable to diagnose PJI before surgery, it is frequently not possible. When the probability for PJI is low, repeat aspirations for cell count determination and microbiology, as well as bone scans, can be helpful in pre-operative diagnostics. In patients with probable but pre-operatively not confirmed PJI, DAIR, or a complete OSE with a radical debridement, is the treatment of choice depending on the timing of presentation. The definite confirmation (or rejection) of the diagnosis of PJI occurs during the early post-operative period. Consequently, empiric antibiotic therapy should be initiated post-operatively until the results of cultures and histology are available.
Practical diagnostic criteria for PJI consist of clinical, histological, cytological, and microbiological tests. The criteria presented in Table 4 are easy to remember and apply, though the limitations in the footnotes must be considered as the specific clinical situation remains the most important element for diagnostic and treatment decisions. Figure 1 provides the diagnostic algorithm together with treatment options for different PJI scenarios.
Data availability
Not applicable.
Code availability
Not applicable.
References
Goldman AH, Sierra RJ, Trousdale RT, Lewallen DG, Berry DJ, Abdel MP (2019) The Lawrence D. Dorr Surgical Techniques & Technologies Award: why are contemporary revision total hip arthroplasties failing? An analysis of 2500 cases. J Arthroplast 34(7S):S11–S16. https://doi.org/10.1016/j.arth.2019.01.031
Takakubo Y, Pajarinen J, Konttinen YT, Trebse R, Coer A, Mackiewicz M, Takagi M, Gallo J (2011) Does it exist something like long-term tolerance to an implant? Aseptic loosening of total hip arthroplasty as a result of local failure of tissue homeostasis. In: Fokter SK (ed) Recent advances in arthroplasty. InTech, Rijeka, pp 324–362
Jaekl DJ, Ong KL, Lau EC, Kurtz SM (2012) The epidemiology of total joint arthroplasty infections. In: Trebse R (ed) Infected total joint arthroplasty. The algorithmic approach. Springer-Verlag, London, pp 35–54
Jakobsen TH, Eickhardt SR, Gheorghe AG, Stenqvist C, Sønderholm M, Stavnsberg C, Jensen PØ, Odgaard A, Whiteley M, Moser C, Hvolris J, Hougen HP, Bjarnsholt T (2018) Implants induce a new niche for microbiomes. APMIS 126(8):685–692. https://doi.org/10.1111/apm.12862
Trivellas M, Cross MB (2016) Irrigation and debridement with component retention. In: Kendoff D, Morgan-Jones R, Haddad FS (eds) Periprosthetic joint infections: changing paradigms. Springer International Publishing, Gewerbestrasse, pp 221–228
Moojen DJ, van Hellemondt G, Vogely HC, Burger BJ, Walenkamp GH, Tulp NJ, Schreurs BW, de Meulemeester FR, Schot CS, van de Pol I, Fujishiro T, Schouls LM, Bauer TW, Dhert WJ (2010) Incidence of low-grade infection in aseptic loosening of total hip arthroplasty. Acta Orthop 81(6):667–673. https://doi.org/10.3109/17453674.2010.525201
Milandt NR, Gundtoft PH, Overgaard S (2019) A single positive tissue culture increases the risk of revision of clinically aseptic THA: a national register study. Clin Orthop Relat Res 477(6):1372–1381. https://doi.org/10.3109/17453674.2015.1023132
Jacobs AME, Bénard M, Meis JF, van Hellemondt G, Goosen JHM (2017) The unsuspected prosthetic joint infection: incidence and consequences of positive intra-operative cultures in presumed aseptic knee and hip revisions. Bone Jt J 99-B(11):1482–1489. https://doi.org/10.1302/0301-620X.99B11.BJJ-2016-0655.R2
Staats K, Kolbitsch P, Sigmund IK, Hobusch GM, Holinka J, Windhager R (2017) Outcome of total hip and total knee revision arthroplasty with minor infection criteria: a retrospective matched-pair analysis. J Arthroplast 32(4):1266–1271. https://doi.org/10.1016/j.arth.2016.11.016
Yang Q, Wang J, Xu Y, Chen Y, Lian Q, Zhang Y (2020) Incidence and risk factors of in-hospital prosthesis-related complications following total hip arthroplasty: a retrospective Nationwide Inpatient Sample database study. Int Orthop 44(11):2243–2252. https://doi.org/10.1007/s00264-020-04682-y
Sierra JM, García S, Martínez-Pastor JC, Tomás X, Gallart X, Vila J, Bori G, Maculé F, Mensa J, Riba J, Soriano A (2011) Relationship between the degree of osteolysis and cultures obtained by sonication of the prostheses in patients with aseptic loosening of a hip or knee arthroplasty. Arch Orthop Trauma Surg 131(10):1357–1361. https://doi.org/10.1007/s00402-011-1307-4
Fernandez-Sampedro M, Salas-Venero C, Fariñas-Álvarez C, Sumillera M, Pérez-Carro L, Fakkas-Fernandez M, Gómez-Román J, Martínez-Martínez L, Fariñas MC (2015) 26Postoperative diagnosis and outcome in patients with revision arthroplasty for aseptic loosening. BMC Infect Dis 15:232. https://doi.org/10.1186/s12879-015-0976-y
Ribera A, Morata L, Moranas J, Agulló JL, Martínez JC, López Y, García D, Cabo J, García-Ramiro S, Soriano A, Murillo O (2014) Clinical and microbiological findings in prosthetic joint replacement due to aseptic loosening. J Infect 69(3):235–243. https://doi.org/10.1016/j.jinf.2014.05.003
Trebse R, Brce A (2012) Current treatment strategies in prosthetic joint infections. In: Trebse R (ed) Infected total joint arthroplasty; the algorithmic approach. Springer-Verlag, London, pp 215–247
Shi X, Yang J, Zhou Z, Shen B, Kang P, Pei F (2020) Partial implant retention in two-stage exchange for chronic infected total hip arthroplasty. Int Orthop 44(3):461–469. https://doi.org/10.1007/s00264-019-04473-0
Karczewski D, Winkler T, Perka C, Müller M (2018) The preoperative microbial detection is no prerequisite for the indication of septic revision in cases of suspected periprosthetic joint infection. Biomed Res Int:1729605. https://doi.org/10.1155/2018/1729605
Iqbal F, Shafiq B, Zamir M, Noor S, Memon N, Memon N, Dina TK (2020) Micro-organisms and risk factors associated with prosthetic joint infection following primary total knee replacement-our experience in Pakistan. Int Orthop 44(2):283–289. https://doi.org/10.1007/s00264-019-04472-1
Moreira AI, Mendes L, Pereira JA (2020) Is there scientific evidence to support antibiotic prophylaxis in patients with periodontal disease as a means to decrease the risk of prosthetic joint infections? A systematic review. Int Orthop 44(2):231–236. https://doi.org/10.1007/s00264-019-04433-8
Trebse R, Levasic V, Milosev I, Kovac S (2014) Does the bearing type influence the incidence of periprosthetic infections of the hip? CeraNews 1:12–16
Yahia SA, Zeller V, Desplaces N, Chazerain P, Lhotellier L, Marmor S, Ziza JM (2016) Crystal-induced arthritis after arthroplasty: 7 cases. Joint Bone Spine 83(5):559–562. https://doi.org/10.1016/j.jbspin.2016.01.006
Mihalic R, Trebse R (2020) Reactive arthritis provoked by Campylobacter jejuni enterocolitis mimicking prosthetic joint infection: a case report. JBJS Case Connect 10(3):e2000043. https://doi.org/10.2106/JBJS.CC.20.00043
Krenn V, Morawietz L, Perino G, Kienapfel H, Ascherl R, Hassenpflug GJ, Thomsen M, Thomas P, Huber M, Kendoff D, Baumhoer D, Krukemeyer MG, Natu S, Boetner F, Zustin J, Kölbel B, Rüther W, Kretzer JP, Tiemann A, Trampuz A, Frommelt L, Tichilow R, Söder S, Müller S, Parvizi J, Illgner U, Gehrke T (2014) Revised histopathological consensus classification of joint implant related pathology. Pathol Res Pract 210(12):779–786. https://doi.org/10.1016/j.prp.2014.09.017
Tsaras G, Maduka-Ezeh A, Inwards CY, Mabry T, Erwin PJ, Murad MH, Montori VM, West CP, Osmon DR, Berbari EF (2012) Utility of intraoperative frozen section histopathology in the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 94(18):1700–1711. https://doi.org/10.2106/JBJS.K.00502
Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R (2004) Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 117(8):556–562. https://doi.org/10.1016/j.amjmed.2004.06.022
Zmistowski B, Della Valle C, Bauer TW, Mallizos IN, Alavi A, Bedair H, Booth RE, Choong P, Deirmengian C, Ehrlich GD, Gambir A, Huang R, Kissin Y, Kobayashi H, Kobayashi N, Krenn V, Lorenzo D, Marston SB, Meermans G, Perez J, Ploegmakers JJ, Rosenberg A, Simpfendorfer C, Thomas P, Tohtz S, Villafuerte JA, Wahl P, Wagenaar FC, Witzo E (2014) Diagnosis of periprosthetic joint infection. J Arthroplast 29(2 Suppl):77–83. https://doi.org/10.1016/j.arth.2013.09.040
Krenn V, Perino G (2017) Histological diagnosis of implant-associated pathologies. In: Krenn V, Perino G (eds) Histological diagnosis of implant-associated pathologies, 1st edn. Springer-Verlag, Berlin, pp 1–44
Krenn VT, Liebisch M, Kölbel B, Renz N, Gehrke T, Huber M, Krukemeyer MG, Trampuz A, Resch H, Krenn V (2017) CD15 focus score: infection diagnosis and stratification into low-virulence and high-virulence microbial pathogens in periprosthetic joint infection. Pathol Res Pract 213(5):541–547. https://doi.org/10.1016/j.prp.2017.01.002
Randelli F, Brioschi M, Randelli P, Ambrogi F, Sdao S, Aliprandi A (2018) Fluoroscopy- vs ultrasound-guided aspiration techniques in the management of periprosthetic joint infection: which is the best? Radiol Med 123(1):28–35. https://doi.org/10.1007/s11547-017-0811-1
Fritz J, Lurie B, Miller TT (2013) Imaging of hip arthroplasty. Semin Musculoskelet Radiol 17(3):316–327. https://doi.org/10.1055/s-0033-1348098
Hargunani R, Madani H, Khoo M, Fotiadou A, Pressney I, Calleja M, O'Donnell P (2016) Imaging of the painful hip arthroplasty. Can Assoc Radiol J 67(4):345–355. https://doi.org/10.1016/j.carj.2015.11.003
Dinneen A, Guyot A, Clements J, Bradley N (2013) Synovial fluid white cell and differential count in the diagnosis or exclusion of prosthetic joint infection. Bone Jt J 95:554–557. https://doi.org/10.1302/0301-620X.95B4.30388
Schinsky MF, Della Valle CJ, Sporer SM, Paprosky WG (2008) Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg Am 90(9):1869–1875. https://doi.org/10.2106/JBJS.G.01255
Cipriano CA, Brown NM, Michael AM, Moric M, Sporer SM, Della Valle CJ (2012) Serum and synovial fluid analysis for diagnosing chronic periprosthetic infection in patients with inflammatory arthritis. J Bone Joint Surg Am 94(7):594–600. https://doi.org/10.2106/JBJS.J.01318
Sousa R, Serrano P, Gomes Dias J, Oliveira JC, Oliveira A (2017) Improving the accuracy of synovial fluid analysis in the diagnosis of prosthetic joint infection with simple and inexpensive biomarkers: C-reactive protein and adenosine deaminase. Bone Jt J 99-B(3):351–357. https://doi.org/10.1302/0301-620X.99B3.BJJ-2016-0684.R1
De Fine M, Giavaresi G, Fini M, Illuminati A, Terrando S, Pignatti G (2018) The role of synovial fluid analysis in the detection of periprosthetic hip and knee infections: a systematic review and meta-analysis. Int Orthop 42(5):983–994. https://doi.org/10.1007/s00264-018-3865-3
Shohat N, Goswami K, Fillingham Y, Tan TL, Calkins T, Della Valle CJ, George J, Higuera C, Parvizi J (2018) Diagnosing periprosthetic joint infection in inflammatory arthritis: assumption is the enemy of true understanding. J Arthroplast 33(11):3561–3566. https://doi.org/10.1016/j.arth.2018.07.016
Fink B, Makowiak C, Fuerst M, Berger I, Schäfer P, Frommelt L (2008) The value of synovial biopsy, joint aspiration and C-reactive protein in the diagnosis of late peri-prosthetic infection of total knee replacements. J Bone Joint Surg (Br) 90(7):874–878. https://doi.org/10.1302/0301-620X.90B7.20417
Trampuz A, Osmon DR, Hanssen AD, Steckelberg JM, Patel R (2003) Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res 414:69–88. https://doi.org/10.1097/01.blo.0000087324.60612.93
Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27(2):302–345. https://doi.org/10.1128/CMR.00111-13
Suren C, Feihl S, Cabric S, Banke IJ, Haller B, Trampuz A, von Eisenhart-Rothe R, Prodinger PM (2020) Improved pre-operative diagnostic accuracy for low-grade prosthetic joint infections using second-generation multiplex polymerase chain reaction on joint fluid aspirate. Int Orthop 44(9):1629–1637. https://doi.org/10.1007/s00264-020-04552-7
Hughes JG, Vetter EA, Patel R, Schleck CD, Harmsen S, Turgeant LT, Cockerill FR (2001) Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J Clin Microbiol 39(12):4468–4471. https://doi.org/10.1128/JCM.39.12.4468-4471.2001
Kheir MM, Tan TL, Ackerman CT, Modi R, Foltz C, Parvizi J (2018) Culturing periprosthetic joint infection: number of samples, growth duration, and organisms. J Arthroplast 33(11):3531–3536. https://doi.org/10.1016/j.arth.2018.06.018
Aggarwal VK, Higuera C, Deirmengian G, Parvizi J, Austin MS (2013) Swab cultures are not as effective as tissue cultures for diagnosis of periprosthetic joint infection. Clin Orthop Relat Res 471(10):3196–3203. https://doi.org/10.1007/s11999-013-2974-y
Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar IN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R (2007) Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357(7):654–663. https://doi.org/10.1056/nejmoa061588
Trampuz A, Piper KE, Hanssen AD, Osmon DR, Cockerill FR, Steckelberg JM, Patel R (2006) Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol 44(2):628–631. https://doi.org/10.1128/JCM.44.2.628-631.2006
Portillo ME, Salvadó M, Trampuz A, Siverio A, Alier A, Sorli L, Martínez S, Pérez-Prieto D, Horcajada JP, Puig-Verdie L (2015) Improved diagnosis of orthopedic implant-associated infection by inoculation of sonication fluid into blood culture bottles. J Clin Microbiol 53(5):1622–1627. https://doi.org/10.1128/JCM.03683-14
Janz V, Trampuz A, Perka CF, Wassilew GI (2017) Reduced culture time and improved isolation rate through culture of sonicate fluid in blood culture bottles. Technol Health Care 25(4):635–640. https://doi.org/10.3233/THC-160660
Dudareva M, Barrett L, Figtree M, Scarborough M, Watanabe M, Newnham R, Wallis R, Oakley S, Kendrick B, Stubbs D, McNally MA, Bejon P, Atkins BA, Taylor A, Brent AJ (2018) Sonication versus tissue sampling for diagnosis of prosthetic joint and other orthopedic device-related infections. J Clin Microbiol 56(12):e00688–e00618. https://doi.org/10.1128/JCM.00688-18
Puig-Verdie L, Alentorn-Geli E, Gonzalez-Cuevas A, Sorlı L, Salvado M, Alier A, Pelfort X, Portillo ME, Horcajada JP (2013) Implant sonication increases the diagnostic accuracy of infection in patients with delayed, but not early, orthopaedic implant failure. Bone Jt J 95-B(2):244–249. https://doi.org/10.1302/0301-620X.95B2.30486
Kummer A, Tafin UF, Borens O (2017) Effect of sonication on the elution of antibiotics from polymethyl methacrylate (PMMA). J Bone Jt Infect 2(4):208–212. https://doi.org/10.7150/jbji.22443
Akgün D, Müller M, Perka C, Winkler T (2018) The serum level of C-reactive protein alone cannot be used for the diagnosis of prosthetic joint infections, especially in those caused by organisms of low virulence. Bone Jt J 100-B(11):1482–1486. https://doi.org/10.1302/0301-620X.100B11.BJJ-2018-0514.R1
Dodson CC, Craig EV, Cordasco FA, Dines DM, Dines JS, Dicarlo E, Brause BD, Warren RF (2010) Propionibacterium acnes infection after shoulder arthroplasty: a diagnostic challenge. J Shoulder Elb Surg 19(2):303–307. https://doi.org/10.1016/j.jse.2009.07.065
Bejon P, Byren I, Atkins BL, Scarborough M, Woodhouse A, McLardy-Smith P, Gundle R, Berendt AR (2011) Serial measurement of the C-reactive protein is a poor predictor of treatment outcome in prosthetic joint infection. J Antimicrob Chemother 66(7):1590–1593. https://doi.org/10.1093/jac/dkr182
Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Jt Bone Surg Am 92(11):2102–2119. https://doi.org/10.2106/JBJS.I.01199
Trebse R, Mihalic R (2014) Acute osteomyelitis in children. N Engl J Med 370(14):1364–1365. https://doi.org/10.1056/NEJMc1402234
Li R, Shao HY, Hao LB, Yu BZ, Qu PF, Zhou YX, Chen JY (2019) Plasma fibrinogen exhibits better performance than plasma D-dimer in the diagnosis of periprosthetic joint infection: a multicenter retrospective study. J Bone Joint Surg Am 101(7):613–619. https://doi.org/10.2106/JBJS.18.00624
Levon J, Al Samadi A, Mackiewicz Z, Coer A, Trebse R, Waris E, Konttinen Y (2015) Human beta-defensin-3 producing cells in septic implant loosening. J Mater Sci Mater Med 26(2):98. https://doi.org/10.1007/s10856-015-5440-4
Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J (2014) Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res 472(11):3254–3262. https://doi.org/10.1007/s11999-014-3543-8
Gehrke T, Lausmann C, Citak M, Bonanzinga T, Frommelt L, Zahar A (2018) The accuracy of the alpha defensin lateral flow device for diagnosis of periprosthetic joint infection: comparison with a gold standard. J Bone Joint Surg Am 100(1):42–48. https://doi.org/10.2106/JBJS.16.01522
Bingham J, Clarke H, Spangehl M, Schwartz A, Beauchamp C, Goldberg B (2014) The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty. Clin Orthop Relat Res 472(12):4006–4009. https://doi.org/10.1007/s11999-014-3900-7
Sigmund IK, Holinka J, Gamper J, Staats K, Böhler C, Kubista B, Windhager R (2017) Qualitative a-defensin test (Synovasure) for the diagnosis of periprosthetic infection in revision total joint arthroplasty. Bone Jt J 99-B(1):66–72. https://doi.org/10.1302/0301-620X.99B1.BJJ-2016-0295.R1
Rak M, Barlic-Maganja D, Kavcic M, Trebse R, Cőr A (2013) Comparison of molecular and culture method in diagnosis of prosthetic joint infection. FEMS Microbiol Lett 343(1):42–48. https://doi.org/10.1111/1574-6968.12125
Rak M, Trebse R (2015) Identification of the same species in at least two intraoperative samples for prosthetic joint infection diagnostics yields the best results with broad-range PCR. Int Orthop 39(5):975–979. https://doi.org/10.1007/s00264-014-2552-2
Li M, Zeng Y, Wu Y, Si H, Bao X, Shen B (2019) Performance of sequencing assays in diagnosis of prosthetic joint infection: a systematic review and meta-analysis. J Arthroplast 34(7):1514–1522. https://doi.org/10.1016/j.arth.2019.02.044
Wouthuyzen-Bakker M, Ploegmakers JJW, Ottink K, Kampinga GA, Wagenmakers-Huizenga L, Jutte PC, Kobold ACM (2018) Synovial calprotectin: an inexpensive biomarker to exclude a chronic prosthetic joint infection. J Arthroplast 33(4):1149–1153. https://doi.org/10.1016/j.arth.2017.11.006
Lee YS, Koo KH, Kim HJ, Tian S, Kim TY, Maltenfort MG, Chen AF (2017) Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 99(24):2077–2084. https://doi.org/10.2106/JBJS.17.00123
Karbysheva S, Yermak K, Grigoricheva L, Renz N, Perka C, Trampuz A (2020) Synovial fluid d-lactate: a novel pathogen-specific biomarker for the diagnosis of periprosthetic joint infection. J Arthroplast 35(8):2223–2229. https://doi.org/10.1016/j.arth.2020.03.016
Signore A, Sconfienza LM, Borens O, Glaudemans AWJM, Cassar-Pullicino V, Trampuz A, Winkler H, Gheysens O, Vanhoenacker FMHM, Petrosillo N, Jutte PC (2019) Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement). Eur J Nucl Med Mol Imaging 46(4):971–988. https://doi.org/10.1007/s00259-019-4263-9
Funding
The authors have received no funding for this paper.
Author information
Authors and Affiliations
Contributions
The authors have contributed equally to the final paper.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Trebse, R., Roskar, S. Evaluation and interpretation of prosthetic joint infection diagnostic investigations. International Orthopaedics (SICOT) 45, 847–855 (2021). https://doi.org/10.1007/s00264-021-04958-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-021-04958-x